Across TCGA pan-cancer cohorts, MBLAC1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MBLAC1 data layer compared with 17 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MBLAC1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated MBLAC1 expression acts as an unfavorable survival marker.

UCEC and PDAC are the cancer types where MBLAC1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	II,III,IV	0.557	1.000	.031	8	view →
PDAC	DFS	Quartile	All	0.738	0.879	.033	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MBLAC1 tumor-vs-normal RNA expression · all MBLAC1 data types